Cargando…
Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence
BACKGROUND: In biomedical prevention trials, correct and consistent use of the investigational product is crucial to determine efficacy. Product adherence in VOICE, a phase 2B randomized trial of a vaginal gel and oral tablets for HIV prevention, was low (~ 34%), yet self-reported adherence and rete...
Autores principales: | Katz, Ariana W. K., Mensch, Barbara S., Woeber, Kubashni, Musara, Petina, Etima, Juliane, van der Straten, Ariane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347781/ https://www.ncbi.nlm.nih.gov/pubmed/30683103 http://dx.doi.org/10.1186/s12905-019-0713-6 |
Ejemplares similares
-
Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study
por: Luecke, Ellen H, et al.
Publicado: (2016) -
Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study
por: van der Straten, Ariane, et al.
Publicado: (2016) -
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study
por: Garcia, Morgan, et al.
Publicado: (2021) -
Influences on willingness to use vaginal or oral HIV PrEP during pregnancy and breastfeeding in Africa: the multisite MAMMA study
por: van der Straten, Ariane, et al.
Publicado: (2020) -
Making the Case for Joint Decision‐Making in Future Multipurpose Prevention Technology (MPT) Choice: Qualitative Findings on MPT Attribute Preferences from the CUPID Study (MTN‐045)
por: Bhushan, Nivedita L., et al.
Publicado: (2022)